SXTPW 60 DEGREES PHARMACEUTICALS I
Follow*W EXP 07/12/202 (warrant or right), issuer CIK 1946563
Filings received so far for Q3 2026: 5 13F filers report a position in SXTPW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Walleye Capital LLCin group Walleye Capital LLC | 200,481 | $5.05K | <0.01% | 0 | 13F-HRTimelineGroup |
| Clear Street Group Inc.in group Clear Street Group Inc. | 145,969 | $3.68K | <0.01% | 0 | 13F-HRTimelineGroup |
| TORNO CAPITAL, LLC | 47,169 | $1.19K | <0.01% | 0 | 13F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them. |
| UBS Group AGin group UBS Group AG | 1,368 | $38 | <0.01% | +721 | 13F-HRTimelineGroup |
| Virtu Financial LLCin group Virtu Financial LLC | 11,552 | $0 | 0% | new | 13F-HRTimelineGroupValue filed as zero, left out of ratios. |